Spop Promotes Skeletal Development and Homeostasis by Positively Regulating Ihh Signaling
Overview
Authors
Affiliations
Indian Hedgehog (Ihh) regulates chondrocyte and osteoblast differentiation through the Glioma-associated oncogene homolog (Gli) transcription factors. Previous in vitro studies suggested that Speckle-type POZ protein (Spop), part of the Cullin-3 (Cul3) ubiquitin ligase complex, targets Gli2 and Gli3 for degradation and negatively regulates Hedgehog (Hh) signaling. In this study, we found defects in chondrocyte and osteoblast differentiation in Spop-null mutant mice. Strikingly, both the full-length and repressor forms of Gli3, but not Gli2, were up-regulated in Spop mutants, and Ihh target genes Patched 1 (Ptch1) and parathyroid hormone-like peptide (Pthlh) were down-regulated, indicating compromised Hh signaling. Consistent with this finding, reducing Gli3 dosage greatly rescued the Spop mutant skeletal defects. We further show that Spop directly targets the Gli3 repressor for ubiquitination and degradation. Finally, we demonstrate in a conditional mutant that loss of Spop results in brachydactyly and osteopenia, which can be rescued by reducing the dosage of Gli3. In summary, Spop is an important positive regulator of Ihh signaling and skeletal development.
Regulatory mechanisms governing GLI proteins in hedgehog signaling.
Yoshida S, Yoshida K Anat Sci Int. 2024; 100(2):143-154.
PMID: 39576500 DOI: 10.1007/s12565-024-00814-1.
Zhu S, Chen W, Masson A, Li Y Cell Discov. 2024; 10(1):71.
PMID: 38956429 PMC: 11219878. DOI: 10.1038/s41421-024-00689-6.
Yamashita E, Negishi S, Kikuta J, Shimizu M, Senpuku H Dent J (Basel). 2024; 12(4).
PMID: 38668020 PMC: 11049549. DOI: 10.3390/dj12040108.
The role of E3 ubiquitin ligases in bone homeostasis and related diseases.
Dong Y, Chen Y, Ma G, Cao H Acta Pharm Sin B. 2023; 13(10):3963-3987.
PMID: 37799379 PMC: 10547920. DOI: 10.1016/j.apsb.2023.06.016.
SPOPL induces tumorigenicity and stemness in glioma stem cells by activating Notch signaling.
Hu T, Xuan R, Han E, Cai L, Xia Z J Neurooncol. 2023; 164(1):157-170.
PMID: 37523046 DOI: 10.1007/s11060-023-04394-4.